Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Enterobacteriaceae Infections | 7 | 2019 | 529 | 1.53 | Why? |
| beta-Lactamases | 7 | 2019 | 759 | 1.17 | Why? |
| Enterobacteriaceae | 5 | 2019 | 395 | 1.02 | Why? |
| Mycoses | 2 | 2020 | 589 | 0.95 | Why? |
| Pneumonia, Ventilator-Associated | 4 | 2019 | 861 | 0.69 | Why? |
| Molecular Typing | 1 | 2018 | 280 | 0.64 | Why? |
| Pathology, Molecular | 1 | 2018 | 343 | 0.56 | Why? |
| Cross Infection | 9 | 2019 | 8675 | 0.49 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 711 | 0.48 | Why? |
| Klebsiella pneumoniae | 2 | 2018 | 658 | 0.48 | Why? |
| Klebsiella Infections | 1 | 2017 | 466 | 0.47 | Why? |
| Medical Errors | 1 | 2013 | 201 | 0.42 | Why? |
| Anti-Bacterial Agents | 12 | 2019 | 10083 | 0.39 | Why? |
| Staphylococcal Infections | 1 | 2019 | 1099 | 0.39 | Why? |
| Bacteremia | 1 | 2019 | 1372 | 0.35 | Why? |
| Diagnostic Tests, Routine | 1 | 2019 | 2643 | 0.34 | Why? |
| Intensive Care Units | 15 | 2021 | 29594 | 0.32 | Why? |
| Drug Resistance, Multiple, Bacterial | 2 | 2018 | 1115 | 0.31 | Why? |
| Carbapenems | 2 | 2018 | 343 | 0.27 | Why? |
| Carrier State | 3 | 2018 | 2100 | 0.22 | Why? |
| Invasive Pulmonary Aspergillosis | 2 | 2021 | 634 | 0.21 | Why? |
| Wind | 1 | 2021 | 144 | 0.21 | Why? |
| Drug Resistance, Multiple | 2 | 2018 | 156 | 0.20 | Why? |
| Patient Isolation | 1 | 2013 | 3182 | 0.20 | Why? |
| Child Day Care Centers | 1 | 2021 | 208 | 0.18 | Why? |
| Enterobacter cloacae | 1 | 2018 | 58 | 0.18 | Why? |
| Masks | 1 | 2021 | 8528 | 0.18 | Why? |
| Drug Resistance, Multiple, Fungal | 1 | 2018 | 45 | 0.18 | Why? |
| Ascomycota | 1 | 2018 | 71 | 0.17 | Why? |
| Saccharomycetales | 1 | 2018 | 118 | 0.17 | Why? |
| Drug Contamination | 1 | 2018 | 104 | 0.17 | Why? |
| Vancomycin-Resistant Enterococci | 1 | 2018 | 104 | 0.17 | Why? |
| beta-Lactam Resistance | 1 | 2018 | 150 | 0.16 | Why? |
| Medical Records | 1 | 2019 | 513 | 0.16 | Why? |
| beta-Lactams | 1 | 2018 | 210 | 0.15 | Why? |
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2018 | 214 | 0.15 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.15 | Why? |
| Escherichia coli | 3 | 2018 | 1547 | 0.14 | Why? |
| Absidia | 1 | 2013 | 8 | 0.14 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2018 | 323 | 0.14 | Why? |
| Robotics | 1 | 2021 | 528 | 0.14 | Why? |
| France | 6 | 2021 | 12074 | 0.14 | Why? |
| Infection Control | 3 | 2018 | 23131 | 0.13 | Why? |
| Meta-Analysis as Topic | 1 | 2021 | 1289 | 0.13 | Why? |
| Escherichia coli Infections | 1 | 2017 | 348 | 0.13 | Why? |
| Candida | 1 | 2018 | 425 | 0.13 | Why? |
| Observational Studies as Topic | 1 | 2021 | 1887 | 0.13 | Why? |
| Staphylococcus aureus | 1 | 2019 | 844 | 0.12 | Why? |
| Pneumonia, Bacterial | 1 | 2019 | 843 | 0.12 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 2309 | 0.12 | Why? |
| Pneumococcal Infections | 1 | 2018 | 562 | 0.11 | Why? |
| Incidence | 3 | 2020 | 25622 | 0.11 | Why? |
| Ultraviolet Rays | 1 | 2021 | 1272 | 0.11 | Why? |
| Risk Factors | 7 | 2020 | 71621 | 0.11 | Why? |
| Antifungal Agents | 1 | 2021 | 1828 | 0.10 | Why? |
| Disease Outbreaks | 2 | 2018 | 27595 | 0.10 | Why? |
| Communicable Diseases, Imported | 1 | 2018 | 843 | 0.10 | Why? |
| Antimicrobial Stewardship | 1 | 2017 | 931 | 0.10 | Why? |
| Bacterial Infections | 2 | 2014 | 2229 | 0.09 | Why? |
| Humans | 32 | 2021 | 930598 | 0.09 | Why? |
| Steroids | 1 | 2014 | 904 | 0.09 | Why? |
| Moxalactam | 1 | 2007 | 1 | 0.09 | Why? |
| Antibiotic Prophylaxis | 1 | 2011 | 399 | 0.09 | Why? |
| Drug Resistance, Bacterial | 1 | 2017 | 1414 | 0.09 | Why? |
| Cefoxitin | 1 | 2007 | 11 | 0.09 | Why? |
| Disinfection | 1 | 2021 | 2912 | 0.08 | Why? |
| Methicillin Resistance | 1 | 2007 | 77 | 0.08 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2013 | 669 | 0.08 | Why? |
| Cause of Death | 1 | 2021 | 4823 | 0.08 | Why? |
| Whole Genome Sequencing | 1 | 2018 | 3239 | 0.08 | Why? |
| Staphylococcus | 1 | 2007 | 77 | 0.08 | Why? |
| Qualitative Research | 1 | 2019 | 4337 | 0.08 | Why? |
| Mucormycosis | 1 | 2013 | 832 | 0.07 | Why? |
| Logistic Models | 1 | 2019 | 9089 | 0.07 | Why? |
| Case-Control Studies | 3 | 2018 | 17671 | 0.07 | Why? |
| Air Pollutants | 1 | 2021 | 3110 | 0.07 | Why? |
| Predictive Value of Tests | 1 | 2019 | 9537 | 0.06 | Why? |
| Hospitals | 2 | 2021 | 11793 | 0.06 | Why? |
| Aged | 10 | 2021 | 215776 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.05 | Why? |
| Appendicitis | 1 | 2011 | 946 | 0.05 | Why? |
| Travel | 2 | 2018 | 7220 | 0.05 | Why? |
| Retrospective Studies | 4 | 2020 | 105322 | 0.05 | Why? |
| Microbial Sensitivity Tests | 3 | 2018 | 2886 | 0.05 | Why? |
| Cephalosporinase | 1 | 2018 | 12 | 0.05 | Why? |
| Cefotaxime | 1 | 2018 | 31 | 0.05 | Why? |
| Chaperonin 60 | 1 | 2018 | 42 | 0.05 | Why? |
| Female | 13 | 2021 | 380317 | 0.04 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.04 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.04 | Why? |
| Male | 12 | 2021 | 367725 | 0.04 | Why? |
| Escherichia coli Proteins | 1 | 2018 | 168 | 0.04 | Why? |
| Pneumonia | 1 | 2017 | 5652 | 0.04 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.04 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.04 | Why? |
| Ceftriaxone | 1 | 2018 | 365 | 0.04 | Why? |
| Critical Illness | 2 | 2016 | 17281 | 0.04 | Why? |
| Postoperative Complications | 1 | 2013 | 5861 | 0.03 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Hospital Mortality | 1 | 2018 | 22087 | 0.03 | Why? |
| Streptococcus pneumoniae | 1 | 2018 | 827 | 0.03 | Why? |
| Stomach | 1 | 2013 | 141 | 0.03 | Why? |
| Immunocompetence | 1 | 2014 | 280 | 0.03 | Why? |
| Lung Diseases, Fungal | 1 | 1993 | 167 | 0.03 | Why? |
| Streptococcus milleri Group | 1 | 2011 | 1 | 0.03 | Why? |
| Child, Preschool | 4 | 2021 | 36283 | 0.03 | Why? |
| Public Health | 1 | 2018 | 16359 | 0.03 | Why? |
| Pancreas Transplantation | 1 | 2013 | 163 | 0.03 | Why? |
| Adult | 6 | 2021 | 244371 | 0.03 | Why? |
| Enterococcus | 1 | 2011 | 73 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Intestine, Small | 1 | 2013 | 336 | 0.03 | Why? |
| Disinfectants | 1 | 2021 | 1077 | 0.03 | Why? |
| Aspergillosis | 1 | 1993 | 264 | 0.03 | Why? |
| Infant | 3 | 2021 | 30274 | 0.03 | Why? |
| Neutropenia | 1 | 1993 | 388 | 0.03 | Why? |
| Young Adult | 2 | 2018 | 93724 | 0.02 | Why? |
| Ascitic Fluid | 1 | 2011 | 169 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2018 | 2830 | 0.02 | Why? |
| Basic Reproduction Number | 1 | 2021 | 2676 | 0.02 | Why? |
| Environmental Monitoring | 1 | 2021 | 3143 | 0.02 | Why? |
| Colon | 1 | 2013 | 669 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Chi-Square Distribution | 1 | 2011 | 961 | 0.02 | Why? |
| Penicillin-Binding Proteins | 1 | 2007 | 31 | 0.02 | Why? |
| Coagulase | 1 | 2007 | 44 | 0.02 | Why? |
| Prospective Studies | 3 | 2018 | 43301 | 0.02 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.02 | Why? |
| Staphylococcus epidermidis | 1 | 2007 | 53 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| Severity of Illness Index | 1 | 2014 | 48226 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| Hospitals, University | 1 | 2018 | 4173 | 0.02 | Why? |
| Critical Care | 2 | 2019 | 14081 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.02 | Why? |
| Consensus | 1 | 2019 | 6345 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2017 | 2844 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2017 | 3755 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| Comorbidity | 2 | 2018 | 34796 | 0.01 | Why? |
| Preoperative Care | 1 | 2011 | 1515 | 0.01 | Why? |
| Bacterial Proteins | 1 | 2007 | 1318 | 0.01 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.01 | Why? |
| Immunocompromised Host | 1 | 1993 | 5150 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Child | 2 | 2018 | 70012 | 0.01 | Why? |
| ROC Curve | 1 | 2007 | 6024 | 0.01 | Why? |
| Adolescent | 2 | 2018 | 86841 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Treatment Outcome | 1 | 2019 | 51732 | 0.01 | Why? |
| Amphotericin B | 1 | 1993 | 256 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2017 | 22116 | 0.01 | Why? |
| Pneumonectomy | 1 | 1993 | 278 | 0.01 | Why? |
| Hospitalization | 1 | 2018 | 54280 | 0.01 | Why? |
| Leukemia, Myeloid, Acute | 1 | 1993 | 676 | 0.01 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1993 | 1573 | 0.00 | Why? |
| Survival Rate | 1 | 1993 | 9206 | 0.00 | Why? |
| Follow-Up Studies | 1 | 1993 | 17020 | 0.00 | Why? |